← Leaderboards
Patrice E. Fort
University Of Michigan At Ann Arbor
$5,914,612
Attributed
$7,048,411
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,048,411 · 5
By mechanism
R01$5,790,886 · 3
T32$1,046,947 · 1
R41$210,578 · 1
Top collaborators
- Steve F Abcouwer4 shared
- Peter S Distefano1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Jerry A Stitzel$8,602,479
- Catherine A Collins$5,234,223
- Xing Fan$5,437,064
- Ronald D Chervin$24,941,680
- Kate Francesca Barald$7,646,384
Others in their field
Top investigators on “Vision”
- Chanza Baytop · Westat, Inc.$271,217,917
- Edward W Maly · United Nations Children'S Fund$264,005,699
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Everette D Joseph · Howard University$243,972,016
Research focus
VisionProteinsDiabetic RetinopathyDiabetes MellitusCellsNeuronsRetinaDiabeticAffectRetinal NeuronPathway InteractionsCell SurvivalRetinal DiseasesStressBaseNovel StrategiesBlindnessAnimalsIn VivoPhosphotransferasesPreventChronicCrystallinsAlpha-Crystallins
Grant awards (22)
Vision Research Training Program$168,423
T32 · FY2025 · EY · contact PI
Vision Research Training Program$172,632
T32 · FY2024 · EY · contact PI
Role of mTORC1 in Retinal Ganglion Cell Physiology and Disease$522,087
R01 · FY2023 · EY
Vision Research Training Program$170,766
T32 · FY2023 · EY · contact PI
Protective potential of functionally enhanced AlphaA-crystallin in neurodegeneration$553,828
R01 · FY2022 · EY · contact PI
Role of mTORC1 in Retinal Ganglion Cell Physiology and Disease$506,423
R01 · FY2022 · EY
Vision Research Training Program$163,976
T32 · FY2022 · EY · contact PI
Role of mTORC1 in Retinal Ganglion Cell Physiology and Disease$506,423
R01 · FY2021 · EY
Vision Research Training Program$153,004
T32 · FY2021 · EY · contact PI
Role of mTORC1 in Retinal Ganglion Cell Physiology and Disease$522,087
R01 · FY2020 · EY
Treatment of diabetic retinopathy with TrkB agonist antibodies$210,578
R41 · FY2020 · EY
Vision Research Training Program$151,400
T32 · FY2020 · EY · contact PI
Progressive Impact of Diabetes on Retinal Neuroprotection by ?-Crystallins$390,002
R01 · FY2019 · EY · contact PI
Vision Research Training Program$66,746
T32 · FY2019 · EY · contact PI
Progressive Impact of Diabetes on Retinal Neuroprotection by ?-Crystallins$390,002
R01 · FY2018 · EY · contact PI
Progressive Impact of Diabetes on Retinal Neuroprotection by ?-Crystallins$88,312
R01 · FY2018 · EY · contact PI
Progressive Impact of Diabetes on Retinal Neuroprotection by ?-Crystallins$387,917
R01 · FY2017 · EY · contact PI
Progressive impact of diabetes on retinal neuroprotection by alpha-crystallins$387,500
R01 · FY2016 · EY · contact PI
Progressive impact of diabetes on retinal neuroprotection by alpha-crystallins$379,750
R01 · FY2015 · EY · contact PI
Progressive impact of diabetes on retinal neuroprotection by ?-crystallins$380,975
R01 · FY2014 · EY · contact PI
Progressive impact of diabetes on retinal neuroprotection by ?-crystallins$380,414
R01 · FY2013 · EY · contact PI
Progressive impact of diabetes on retinal neuroprotection by ?-crystallins$395,166
R01 · FY2012 · EY · contact PI